Press Releases

Read Regulatory and non-regulatory press releases

  • All
  • Non-Regulatory
  • Regulatory
Regulatory

Oncology Venture has successfully executed capital increase with a value in excess of SEK 80m.

Regulatory

Oncology Venture management participates in current rights issue

Regulatory

Oncology Venture prolongs subscription period

Regulatory

Oncology Venture provides news on its clinical development projects dovitinib, 2X‑121 and LiPlaCis

Non-Regulatory

Oncology Venture Investor Events in Q2 2019 – new event

Non-Regulatory

Oncology Venture Investor Events in Q2 2019

Non-Regulatory

Editorial in Pharmagenomics explains how DRP® can guide the treatment for breast cancer

Regulatory

Correction: Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 – without MAR plate

Regulatory

Oncology Venture today publishes a supplement to the prospectus published April 5, 2019

Non-Regulatory

Oncology Venture invites to a webcast April 8 at 16:30

Regulatory

Oncology Venture hereby publishes a prospectus regarding the rights issue starting on April 17, 2019

Regulatory

The Board of Oncology Venture resolves to conduct a rights issue of new shares

Regulatory

Minutes of Ordinary General Meeting

Regulatory

Oncology Venture obtains option to in-license the European rights to the FDA approved ixabepilone

Regulatory

Dovitinib regulatory strategy confirmed and new combination biomarker DRP PD1/PD-L1 + dovitinib developed. Oncology Venture engages in partnering activities with Destum Partners

Regulatory

Laboratory set up in Berlin and strategic collaboration with leading German and Danish cancer coorporative groups entered to develop precision medicine for women’s cancers

Regulatory

Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed

Regulatory

The observation status of Oncology Venture is removed

Regulatory

Oncology Venture has established bridge loan facility

Regulatory

NOTICE TO CONVENE ORDINARY GENERAL MEETING